Renal Flashcards
Balkan Endemic Nephropathy
Tubulointerstitial disease (fibrous) 2/2 aristocholic acid (endemic to Balkans, also in wt loss supplements). Increased risk transitional cell carcinoma of renal pelvis, ureter, bladder
Type 4 RTA etiologies
Aldosterone deficiency or resistance
Mild-mod CKD 2/2 diabetic nephropathy
Chronic interstitial nephritis: SLE or AIDS
Acute GN
Meds: NSAIDS, calcinuerin inhibs, ACE inhibitors, heparin, trimethoprim
Type 4 RTA presentation
Hyperkalemia
Normal serum AG
Impaired urine acidification (=positive urine AG)
Urine pH
Type 4 RTA w/u
Plasma renin activity
Serum aldosterone
Serum cortisol
Type 1 RTA presentation
Hypokalemia
Normal serum AG
Impaired urine acidification (=positive urine AG)
Urine pH >5.5
Type 2 RTA presentation
Hypokalemia (secondary hyperaldosteronism)
Glycosuria (w normal plasma glucose)
Low molecular weight proteinuria
Phosphaturia
Normal=negative urine AG since urine able to appropriately excrete acid
Thin glomerular basement membrane disease
persistent hematuria, normal kidney function, and positive family history of hematuria without kidney failure
Low C3
Post strep GN Membranoproliferative GN SLE Infection related GN Cryoglobulinemic vasculitis (C4 often low too)
Normal C3
IgA nephropathy IgA vasculitis (aka Henoch Schonlein purpura)
Age to start doing cystoscopy for hematuria
35yo, unless smoker, exposure to cyclophosphamide or analine dye
Cutoff for treatment of hypertension based on ambulatory BP monitoring
135/85 awake, 125/75 asleep
Use average BP
When to start combo anti-HTN
20/10 above goal BP
Aminoglycoside nephrotoxicity features
Onset w/in 5-10d
Non-oliguric
Granular casts in the urine
Gitelman mimics
thiazide diuretic
oncogenic osteomalacia
2/2 benign soft tissue tumor -> overexpression of FGF-23
bone pain/increased alk phos/osteomalacia/fractures, hypophosphatemia, renal phosphorus wasting, low 1,25-dihydroxy VitD w normal 25-hydroxy Vit D
trimethoprim Cr effect
can raise Cr by 0.5 based on change in secretion, not decrease in GFR
FeNa/FeUrea cutoffs for pre-renal
FeNa 2% likely ATN
FeUrea
Treatment class IV SLE nephritis
IV steroids plus IV MMF or IV cyclophosphamide
Orlistat renal effects
Increased intestinal uptake of oxalate -> oxalate nephropathy
Acquired cystic kidney disease
increases with time in ESRD/on HD. large number of small bilateral kidney cysts, reduced kidney size, and a markedly increased (30x) risk for developing renal cell carcinoma